Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEye twitching is not listed as a known side effect of Wegovy (semaglutide) in the UK prescribing information or on the NHS medicines page for semaglutide. If you've noticed an involuntary eyelid twitch after starting treatment, it's understandable to wonder whether the injection is responsible — but the evidence points elsewhere. Most eye twitching has common, everyday causes that have nothing to do with semaglutide. That said, Wegovy is a prescription-only medicine requiring clinical assessment, and any new or persistent symptom during treatment is worth raising with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When a new medicine coincides with a minor symptom, it's natural to connect the two. Eye twitching (the technical term is benign essential blepharospasm or, more commonly, myokymia) is one of those symptoms people notice and then start attributing to whatever changed recently. If that change was starting Wegovy, the association feels logical. It isn't supported by the clinical data, though.
The Wegovy Summary of Product Characteristics, which is the definitive prescribing document reviewed by the MHRA before UK approval, does not list eye twitching at any frequency category, including those classified as rare or very rare. The NHS medicines page for semaglutide similarly describes a side-effect profile dominated by gastrointestinal complaints. Nausea, vomiting, diarrhoea, constipation, reflux and fatigue are the symptoms that appeared repeatedly across the STEP clinical trial programme and that prescribers actually monitor for. Eyelid spasm is not among them.
This doesn't mean your experience is imagined. It means the twitching almost certainly has a different cause, and starting Wegovy happened to coincide with it.
Benign myokymia is extremely common and almost always harmless. The eyelid muscle misfires when the nerve supplying it is irritated or fatigued. In the vast majority of adults, the triggers are:
Poor sleep is the most frequently cited factor. If you recently changed your sleep pattern (perhaps because of nausea in the first few weeks of a new medicine) that's a plausible direct cause. Caffeine amplifies nerve excitability and is a well-documented driver of eyelid spasm; so is stress. Dry eyes, which become more common with age and screen time, are another recognised trigger. Magnesium deficiency has also been linked to muscle twitching more broadly, and it's worth noting that if Wegovy's appetite-reducing effect has significantly changed what you eat, nutritional shifts could be relevant.
These causes are entirely independent of semaglutide. They also tend to resolve on their own within days to a few weeks once the underlying trigger is addressed. If you're wondering whether the medicine itself could be responsible, our page on Wegovy and eye twitching looks at the question in detail and explains what the clinical evidence actually shows.
For a fuller picture of Wegovy's actual side-effect profile, the Wegovy treatment page covers what patients most commonly report.
There is one eye-related caution associated with semaglutide, and it is worth knowing about precisely because it is different from twitching. People with pre-existing diabetic retinopathy (damage to the blood vessels at the back of the eye caused by poorly controlled blood sugar) have experienced worsening of that condition during rapid blood-glucose improvement on GLP-1 medicines. This is a known phenomenon not unique to semaglutide.
The symptoms that warrant urgent medical review are sudden changes in vision (blurring, floaters, or visual disturbance) not eyelid spasm. If you experience any of those, contact your prescriber or GP promptly rather than waiting for a routine appointment. A benign eyelid twitch that you can reproduce by pressing gently on your eye is a different thing entirely.
You can read about other reported physical symptoms on our page about Wegovy and eye-related concerns, which covers what is and isn't documented in the clinical data.
Even symptoms that aren't on a medicine's formal list can be worth discussing, particularly if they are persistent, worsen over time, spread beyond the eyelid to other facial muscles, or come with other neurological signs like numbness or weakness. A twitch lasting more than three weeks with no obvious lifestyle trigger should be assessed by a GP regardless of whether you're on any medication.
If you're also experiencing skin-related symptoms since starting semaglutide, our page on whether semaglutide causes itching looks at that question using the same evidence framework. Our semaglutide overview is also a useful reference for the broader picture of how the medicine works and what side effects are actually documented.
For anything that concerns you during treatment, the right first step is always to contact the team who prescribed for you. At nume, prescriber support is available seven days a week, not just when your first pen arrives. Consultations go to a real clinician on the day they're submitted, and aftercare is part of the service from the start. If you'd like to explore treatment or discuss a symptom with a prescriber, you can start a free consultation whenever you're ready.
It's also worth knowing what the private prescription cost covers before you start. Our Wegovy price page explains what is included in a single transparent fee and how to think about value beyond the headline figure.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.